Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
The Block Act of 2025 prohibits Medicare, Medicaid, group health plans, and private health insurers from covering certain "prohibited organ transplants" beginning January 1, 2026.
A "prohibited organ transplant" is defined as a transplant of listed human organs that occurs in the People’s Republic of China or that is not procured through the U.S. Organ Procurement and Transplantation Network.
The bill makes it a federal crime (up to 2 years imprisonment) and creates civil penalties (triple the cost) for health care providers who knowingly furnish such transplants or related items and services, and directs HHS to issue implementing rules.
Policy taps into bipartisan human-rights concerns but imposes unusual criminal penalties, triggers legal risks, and faces Senate consensus barriers.
Relative to its intended legislative type, this bill is a clearly focused substantive statutory package that enacts crosscutting prohibitions on a defined category of organ transplants, amends multiple statutes to deny coverage, and creates criminal and civil penalties. It specifies definitions, effective dates, and delegates rulemaking authority to HHS for necessary implementation details.
Ethics vs access: human rights concerns versus patient care continuity
Ethics vs access: human rights concerns versus patient care continuity
Likely supportive of prohibiting participation in illicit organ markets and forced organ harvesting.
Concerned about potential harm to patients who receive transplants abroad, enforcement fairness, and impacts on vulnerable populations.
Would push for narrow definitions, clear due-process protections, and robust medical exceptions.
Generally sympathetic to stopping illicit organ trafficking while wary of administrative complexity and unintended patient harm.
Views bill as a reasonable leverage tool but wants precise HHS rulemaking, narrow scope, and transitional guidance.
Will weigh enforcement practicality and fiscal consequences of penalties and compliance burdens.
Likely strongly supportive because the bill restricts Americans' use of foreign organs allegedly tied to illicit practices and counters abuses in China.
Praises criminal penalties and civil deterrents, and appreciates using federal leverage over payments and coverage.
May still want robust enforcement and potentially broader sanctions or immigration consequences tied to organ tourism.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Policy taps into bipartisan human-rights concerns but imposes unusual criminal penalties, triggers legal risks, and faces Senate consensus barriers.
The bill has not accumulated any surfaced votes yet.
Ethics vs access: human rights concerns versus patient care continuity
Policy taps into bipartisan human-rights concerns but imposes unusual criminal penalties, triggers legal risks, and faces Senate consensus…
Relative to its intended legislative type, this bill is a clearly focused substantive statutory package that enacts crosscutting prohibitions on a defined category of organ transplants, amends multiple statutes to deny…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.